| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥47.1B | ¥47.8B | -1.4% |
| Operating Income | ¥-1.6B | ¥-0.1B | -2566.7% |
| Ordinary Income | ¥-1.6B | ¥-0.1B | -1381.8% |
| Net Income | ¥-0.9B | ¥-0.1B | -830.0% |
| ROE | -4.1% | -0.4% | - |
FY2026 Q3 results show revenue of 47.1B yen (YoY -1.4%), operating loss of -1.6B yen (prior period -0.1B yen, deterioration of 1.5B yen), ordinary loss of -1.6B yen (prior period -0.1B yen, deterioration of 1.5B yen), and net loss of -0.9B yen (prior period -0.1B yen, deterioration of 0.8B yen). The company experienced significant profitability deterioration despite relatively stable top-line performance, with operating margin declining from -0.2% to -3.4%. Cash position weakened materially to 2.1B yen (down 62.1% YoY) while short-term borrowings surged 220% to 6.4B yen, indicating heightened liquidity stress. The company maintains full-year guidance of revenue 64.5B yen and operating loss of -1.8B yen, projecting continued losses through fiscal year-end.
Revenue declined modestly by 1.4% YoY to 47.1B yen, with all three business segments experiencing varying degrees of pressure. The Electronics System segment generated sales of 2.3B yen with an operating loss of -0.1B yen, indicating margin compression in the core business. Microelectronics achieved sales of 1.6B yen with operating income of 0.1B yen, representing the only profitable segment with a positive margin of approximately 5.4%. Product Development recorded sales of 0.9B yen with an operating loss of -0.1B yen, reflecting investment-phase characteristics. Gross profit margin remained weak at 14.6%, down from healthier historical levels, as cost of sales consumed 85.4% of revenue. The low gross margin reflects either pricing pressure, unfavorable product mix, or elevated production costs. Selling, general and administrative expenses totaled 8.5B yen, representing 18.0% of revenue and exceeding gross profit by 1.6B yen, driving the operating loss. The SG&A burden appears structurally high relative to the current revenue base, suggesting insufficient operating leverage. Non-operating items contributed minimally to the bottom line, with the gap between operating loss and ordinary loss at approximately 0.03B yen, indicating limited impact from financial income or expenses. The company recorded extraordinary income of 0.3B yen primarily from investment securities sales, which partially offset the operating loss to reduce the net loss to 0.9B yen from a pre-tax loss of 1.4B yen. This non-recurring factor masks the underlying operational weakness. The tax burden coefficient of 0.687 indicates tax benefits or carryforwards that reduced the effective tax impact. The earnings pattern represents revenue flat/profit down, driven by structural margin erosion and fixed cost deleveraging.
Electronics System represents the largest segment with sales of 2.3B yen and operating loss of -0.1B yen, operating at a negative margin of approximately -5.2%. This core business accounts for roughly 48% of reported segment sales and is experiencing significant profitability challenges. Microelectronics delivered sales of 1.6B yen with operating income of 0.1B yen, achieving a positive operating margin of 5.4%, making it the only profitable division. This segment comprises approximately 34% of segment sales and serves as a relative bright spot in the portfolio. Product Development generated sales of 0.9B yen with operating loss of -0.1B yen, operating at a negative margin of approximately -14.8%, representing roughly 18% of segment sales. The substantial loss margin reflects the development-intensive nature of this segment. The material margin differential between Microelectronics (positive 5.4%) and Product Development (negative 14.8%) indicates divergent business economics, with Product Development requiring significant improvement or strategic reassessment. The aggregate segment operating loss aligns with the consolidated operating loss per the segment footnote disclosure.
[Profitability] ROE of -4.1% reflects loss-making operations, with negative net profit margin of -2.0% and operating margin of -3.4%, indicating structural profitability challenges. The company's historical trend shows profitability deterioration from prior periods. [Cash Quality] Cash and deposits of 2.1B yen provide coverage of 0.10 times current liabilities of 21.1B yen, and only 0.33 times short-term debt of 6.4B yen, signaling meaningful liquidity constraints. The cash position declined 62.1% YoY from 5.6B yen, representing substantial cash consumption. [Investment Efficiency] Asset turnover of 0.83 indicates the company generates 0.83 yen of revenue per yen of assets, showing moderate asset utilization. Accounts receivable of 20.1B yen represent 42.7% of revenue, suggesting extended collection cycles. [Financial Health] Equity ratio of 40.3% (22.9B yen equity against 56.9B yen total assets) indicates moderate capitalization. Current ratio of 183.0% appears adequate on surface, though driven primarily by receivables rather than cash. Total interest-bearing debt of 8.8B yen yields debt-to-equity ratio of 0.38, manageable in absolute terms but concerning given negative cash generation. Short-term debt concentration at 73% of total debt creates refinancing risk.
Cash and deposits decreased 3.5B yen YoY to 2.1B yen, representing a 62.1% decline and indicating substantial cash outflow during the period. This reduction occurred despite total assets increasing 2.8B yen to 56.9B yen, suggesting cash was deployed to working capital or debt service. Short-term borrowings surged 4.4B yen to 6.4B yen, a 220% increase, demonstrating reliance on external financing to fund operations. The simultaneous cash decline and borrowing increase signals negative operating cash generation requiring external funding. Current liabilities increased 3.7B yen to 21.1B yen, reflecting accumulation of short-term obligations. Accounts receivable remain elevated at 20.1B yen (35% of total assets), indicating working capital inefficiency with slow conversion to cash. The cash coverage of short-term liabilities deteriorated to 0.10 times from 0.26 times prior period, indicating compressed liquidity buffers. The working capital structure shows heavy reliance on receivables financing rather than cash-backed liquidity, creating vulnerability to collection delays. Long-term debt of 2.4B yen provides some term structure, but the concentration of 73% debt in short-term instruments creates maturity risk. The balance sheet changes indicate operating losses consumed cash, necessitating increased short-term borrowing to maintain business continuity.
Ordinary loss of -1.6B yen versus operating loss of -1.6B yen shows minimal non-operating impact of approximately -0.03B yen, indicating the loss is primarily operational in nature. Non-operating expenses exceed non-operating income marginally, with interest expense representing the primary non-operating burden. The company recorded extraordinary income of 0.3B yen primarily from investment securities sales, which represents a non-recurring gain that improved net loss relative to ordinary loss. This extraordinary income of 0.3B yen represents 0.6% of revenue and is clearly one-time in nature, not indicative of sustainable earnings power. Without this non-recurring gain, the pre-tax loss of 1.4B yen would have translated to a larger net loss. The effective tax rate showed a benefit due to loss carryforwards or tax adjustments, with tax burden coefficient of 0.687 reducing reported net loss. The absence of operating cash flow disclosure limits direct assessment of cash earnings quality, but the 62.1% decline in cash position alongside operating losses strongly suggests negative operating cash flow and poor earnings quality. The deterioration in working capital, particularly the 20.1B yen in receivables requiring conversion, indicates earnings are not cash-backed. The combination of operating losses, dependence on non-recurring gains, and cash position deterioration signals fundamental earnings quality concerns requiring operational restructuring.
The company maintains full-year guidance of revenue 64.5B yen, operating loss -1.8B yen, ordinary loss -1.8B yen, and net loss -1.2B yen. Current period revenue of 47.1B yen represents 73.0% progress against full-year guidance. Assuming this is Q3 (nine-month) results, the 73.0% progress rate is slightly below the expected 75.0% threshold, suggesting modest underperformance in top-line trajectory. Operating loss of -1.6B yen represents 88.9% of the full-year loss guidance of -1.8B yen, indicating the company is tracking close to expected loss levels with one quarter remaining. Net loss of -0.9B yen represents 75.0% of full-year net loss guidance of -1.2B yen, aligning with the expected quarterly run rate. The guidance implies Q4 revenue of approximately 17.4B yen (64.5B minus 47.1B), representing a 36.9% sequential increase from the nine-month average of 15.7B yen per quarter, which appears ambitious without disclosed seasonal patterns or order backlog visibility. The unchanged guidance despite year-to-date losses suggests management maintains confidence in Q4 performance stabilization, though the structural margin issues evident in current results raise questions about Q4 profitability assumptions. The lack of order backlog or contract liability disclosure limits visibility into forward revenue certainty. The guidance reflects expectations for continued operating losses through fiscal year-end, with no indication of near-term return to profitability.
The company forecasts an annual dividend of 15.00 yen per share for the fiscal year despite projecting full-year net loss of -1.2B yen and EPS of -28.12 yen. Based on 4.4 million shares outstanding, the total dividend commitment would approximate 66 million yen. Against the forecasted net loss of -1.2B yen, the payout ratio calculates to negative 5.5%, indicating the company intends to pay dividends from retained earnings or reserves despite current losses. This dividend policy appears disconnected from earnings performance and raises sustainability questions given the 62.1% decline in cash position to 2.1B yen and 220% increase in short-term borrowings to 6.4B yen. The dividend payment of approximately 66 million yen would represent 3.1% of remaining cash reserves, manageable in isolation but concerning within the context of negative operating cash flow and increasing leverage. No share buyback activity is disclosed. The maintenance of dividend payments during loss-making periods may reflect commitment to shareholder returns or concerns about signaling, but creates financial strain given liquidity pressures and lack of cash generation. Investors should monitor whether the dividend is actually paid from available cash or requires additional external financing, which would further deteriorate the balance sheet.
Liquidity and refinancing risk represents the most immediate concern, with cash coverage of short-term debt at only 0.33 times and short-term obligations comprising 73% of total interest-bearing debt. The 6.4B yen short-term borrowing requires refinancing or repayment within one year, while cash reserves of 2.1B yen and negative operating cash flow create meaningful rollover risk. Any tightening of credit conditions or lender hesitancy could precipitate a liquidity crisis. Structural profitability erosion poses medium-term viability risk, with gross margin of 14.6% insufficient to cover SG&A expenses of 18.0% of revenue. The 3.4% operating margin deficit persists across segments except Microelectronics, indicating business model stress. Without pricing power improvement, product mix enhancement, or significant cost restructuring, the company faces prolonged losses potentially eroding equity base and lender confidence. Working capital inefficiency creates cash flow vulnerability, with accounts receivable of 20.1B yen representing 155 days of revenue (annualized basis). Extended collection cycles tie up capital and increase credit risk exposure. Any deterioration in customer credit quality or payment delays would further strain liquidity. The receivables-heavy current asset structure means the 183% current ratio overstates true liquidity resilience.
[Industry Position] (Reference - Proprietary Analysis) The company's financial metrics show significant underperformance relative to manufacturing industry medians. Profitability metrics lag substantially: ROE of -4.1% versus industry median of 5.8% (2025-Q3, n=105) places the company in the bottom decile. Operating margin of -3.4% compares unfavorably to industry median of 8.9% (IQR: 5.4%-12.7%), representing a 12.3 percentage point deficit. Net profit margin of -2.0% trails the industry median of 6.5% (IQR: 3.3%-9.4%) by 8.5 percentage points, reflecting fundamental earning power weakness. Financial health metrics show mixed positioning: Equity ratio of 40.3% falls meaningfully below the industry median of 63.8% (IQR: 49.1%-74.8%), indicating higher leverage than peers. Current ratio of 183% substantially underperforms the industry median of 287% (IQR: 213%-384%), though this partly reflects the company's receivables-heavy working capital structure. Financial leverage of 2.48 exceeds the industry median of 1.53 (IQR: 1.31-1.86), consistent with the lower equity ratio. Efficiency metrics show relative weakness: Asset turnover of 0.83 exceeds the industry median of 0.56 (IQR: 0.41-0.65), representing one area of relative strength in asset utilization. However, operating working capital turnover of approximately 134 days (calculated from receivables of 155 days less payables estimate) compares to industry median of 112 days (IQR: 72-144 days), suggesting room for working capital optimization. Return on assets of -1.6% (calculated from net margin and asset turnover) substantially trails the industry median of 3.4% (IQR: 1.8%-5.2%). The company's negative revenue growth of -1.4% underperforms the industry median growth of 2.8% (IQR: -1.5% to 8.8%), placing it below the 40th percentile. Overall, the company ranks in the bottom quartile across most profitability and growth metrics within the manufacturing sector, while maintaining slightly above-median asset turnover efficiency. (Industry: Manufacturing, n=105 companies, Comparison period: 2025-Q3, Source: Proprietary analysis)
The earnings data reveals three critical characteristics requiring investor attention. First, structural profitability deterioration has accelerated with operating margin declining to -3.4% from near-breakeven levels, driven by gross margin compression to 14.6% and SG&A expense deleveraging. The 88.9% progress toward full-year operating loss guidance with one quarter remaining suggests limited prospect for near-term margin recovery, indicating the need for fundamental business model reassessment rather than cyclical improvement. Second, liquidity stress has intensified materially with cash declining 62.1% to 2.1B yen while short-term borrowings surged 220% to 6.4B yen, creating a compressed 0.33x cash coverage of short-term debt. The 73% concentration of debt in short-term instruments due within one year, combined with apparent negative operating cash flow, creates meaningful refinancing risk and limits financial flexibility for operational restructuring. The maintenance of 15 yen dividend despite losses and cash consumption raises capital allocation sustainability questions. Third, working capital inefficiency constrains cash generation with 20.1B yen receivables representing 155 days sales and 35% of total assets, indicating extended collection cycles tying up scarce liquidity. The receivables-heavy working capital structure means the superficially adequate 183% current ratio overstates true liquidity resilience. These three characteristics collectively indicate a company facing simultaneous operational, financial, and liquidity challenges requiring comprehensive restructuring to restore sustainable performance.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.